Pd Rx Pharmaceutical Stock Technical Analysis
| PDRX Stock | USD 3.33 0.00 0.00% |
As of the 24th of January, Pd Rx owns the market risk adjusted performance of (2.34), and Information Ratio of 0.086. In respect to fundamental indicators, the technical analysis model allows you to check possible technical drivers of Pd Rx Pharmaceutical, as well as the relationship between them.
Pd Rx Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as PDRX, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PDRXPDRX |
Pd Rx 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pd Rx's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pd Rx.
| 10/26/2025 |
| 01/24/2026 |
If you would invest 0.00 in Pd Rx on October 26, 2025 and sell it all today you would earn a total of 0.00 from holding Pd Rx Pharmaceutical or generate 0.0% return on investment in Pd Rx over 90 days. Pd Rx is related to or competes with Sweet Earth, Interpace Biosciences, and Rapid Nutrition. PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the h... More
Pd Rx Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pd Rx's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pd Rx Pharmaceutical upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.086 | |||
| Maximum Drawdown | 14.83 | |||
| Potential Upside | 1.75 |
Pd Rx Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pd Rx's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pd Rx's standard deviation. In reality, there are many statistical measures that can use Pd Rx historical prices to predict the future Pd Rx's volatility.| Risk Adjusted Performance | 0.0973 | |||
| Jensen Alpha | 0.2527 | |||
| Total Risk Alpha | 0.0532 | |||
| Treynor Ratio | (2.35) |
Pd Rx January 24, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0973 | |||
| Market Risk Adjusted Performance | (2.34) | |||
| Mean Deviation | 0.6909 | |||
| Coefficient Of Variation | 806.06 | |||
| Standard Deviation | 2.06 | |||
| Variance | 4.24 | |||
| Information Ratio | 0.086 | |||
| Jensen Alpha | 0.2527 | |||
| Total Risk Alpha | 0.0532 | |||
| Treynor Ratio | (2.35) | |||
| Maximum Drawdown | 14.83 | |||
| Potential Upside | 1.75 | |||
| Skewness | 5.69 | |||
| Kurtosis | 40.18 |
Pd Rx Pharmaceutical Backtested Returns
Pd Rx appears to be slightly risky, given 3 months investment horizon. Pd Rx Pharmaceutical retains Efficiency (Sharpe Ratio) of 0.12, which implies the firm had a 0.12 % return per unit of price deviation over the last 3 months. We have found seventeen technical indicators for Pd Rx, which you can use to evaluate the volatility of the company. Please evaluate Pd Rx's information ratio of 0.086, and Market Risk Adjusted Performance of (2.34) to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Pd Rx holds a performance score of 9. The company owns a Beta (Systematic Risk) of -0.1, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Pd Rx are expected to decrease at a much lower rate. During the bear market, Pd Rx is likely to outperform the market. Please check Pd Rx's risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and rate of daily change , to make a quick decision on whether Pd Rx's current price history will revert.
Auto-correlation | -0.37 |
Poor reverse predictability
Pd Rx Pharmaceutical has poor reverse predictability. Overlapping area represents the amount of predictability between Pd Rx time series from 26th of October 2025 to 10th of December 2025 and 10th of December 2025 to 24th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pd Rx Pharmaceutical price movement. The serial correlation of -0.37 indicates that just about 37.0% of current Pd Rx price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.37 | |
| Spearman Rank Test | 0.34 | |
| Residual Average | 0.0 | |
| Price Variance | 0.05 |
Pd Rx technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Pd Rx Pharmaceutical Technical Analysis
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Pd Rx Pharmaceutical volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Pd Rx Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Pd Rx Pharmaceutical on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Pd Rx Pharmaceutical based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Pd Rx Pharmaceutical price pattern first instead of the macroeconomic environment surrounding Pd Rx Pharmaceutical. By analyzing Pd Rx's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Pd Rx's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Pd Rx specific price patterns or momentum indicators. Please read more on our technical analysis page.
Pd Rx January 24, 2026 Technical Indicators
Most technical analysis of PDRX help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for PDRX from various momentum indicators to cycle indicators. When you analyze PDRX charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0973 | |||
| Market Risk Adjusted Performance | (2.34) | |||
| Mean Deviation | 0.6909 | |||
| Coefficient Of Variation | 806.06 | |||
| Standard Deviation | 2.06 | |||
| Variance | 4.24 | |||
| Information Ratio | 0.086 | |||
| Jensen Alpha | 0.2527 | |||
| Total Risk Alpha | 0.0532 | |||
| Treynor Ratio | (2.35) | |||
| Maximum Drawdown | 14.83 | |||
| Potential Upside | 1.75 | |||
| Skewness | 5.69 | |||
| Kurtosis | 40.18 |
Pd Rx January 24, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as PDRX stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | 0.00 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 3.33 | ||
| Day Typical Price | 3.33 | ||
| Price Action Indicator | 0.00 |
Additional Tools for PDRX Pink Sheet Analysis
When running Pd Rx's price analysis, check to measure Pd Rx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pd Rx is operating at the current time. Most of Pd Rx's value examination focuses on studying past and present price action to predict the probability of Pd Rx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pd Rx's price. Additionally, you may evaluate how the addition of Pd Rx to your portfolios can decrease your overall portfolio volatility.